Fulcrum Therapeutics discontinues its pociredir program after the Food and Drug Administration raises concerns.

Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared ...

Learn how to treat a sickle cell disease crisis at home and when you should go to a medical center for more care.

For generations, Sickle Cell Disease has been a devastating illness affecting millions of people around the world, ...

Fulcrum’s setback is the latest in a series of stumbles for the developers of sickle cell medicines, among them Pfizer, ...

(Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for severe diseases ...

June 1 (Reuters) - Fulcrum Therapeutics said on Monday it would stop developing its experimental sickle-cell disease drug after the U.S. Food and Drug Administration raised cancer-risk concerns, which ...

Afimmune Reports Positive Phase 2 Results for Epeleuton in Sickle Cell Disease, Reducing Vaso-Occlusive Crisis Rate by ...

Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends. It was a contrast to how Cole, 18, spent part of the 2024 holiday ...

In its strategic review, Fulcrum said it will consider alternatives including mergers, acquisitions or other strategic transactions involving the company and its assets. The company has also ...

Serenity Cole lives in St. Louis with her grandmother, Theresa Cole. Serenity is doing well after being one of the first patients to get a gene therapy treatment for sickle cell disease under a new ...